Intracellular degradation of somatostatin-14 following somatostatin- receptor 3-mediated endocytosis in rat insulinoma cells

FEBS Journal

Volumn 275, Issue 19, 2008, Pages 4728-4739

  Roosterman, Dirk ^a,b   Brune, Nicole E I ^c   Kreuzer, Oliver J ^c   Feld, Micha ^b   Pauser, Sylvia ^b   Zarse, Kim ^c   Steinhoff, Martin ^b   Meyerhof, Wolfgang ^c  

^a IZKF Münster ^*  (Germany)

^b Ludwig Boltzmann Institute for Cell and Immunobiology of the Skin   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Endocytosis; G protein coupled receptor; Neuropeptide; Proteolysis; Somatostatin

Indexed keywords

AMMONIUM CHLORIDE; CATHEPSIN D; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCEIN ISOTHIOCYANATE; OCTREOTIDE; RHODAMINE B; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR 3;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSULINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT;

ANIMALS; ENDOCYTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; GREEN FLUORESCENT PROTEINS; INSULINOMA; LYSOSOMES; OCTREOTIDE; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TUMOR CELLS, CULTURED;

RATTUS;

EID: 51749118929     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06606.x     Document Type: Article

References (33)

1. Olias G, Viollet C, Kusserow H, Epelbaum J Meyerhof W (2004) Regulation and function of somatostatin receptors. J Neurochem 89, 1057 1091.
2. Csaba Z Dournaud P (2001) Cellular biology of somatostatin receptors. Neuropeptides 35, 1 23.
3. Reubi JC Laissue JA (1995) Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 16, 110 115.
4. de Herder WW, Hofland LJ, van der Lely AJ Lamberts SW (2003) Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours. Endocr Relat Cancer 10, 451 458.
5. Resmini E, Dadati P, Ravetti JL, Zona G, Spaziante R, Saveanu A, Jaquet P, Culler MD, Bianchi F, Rebora A et al. (2007) Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient. J Clin Endocrinol Metab 92, 1592 1599.
6. Moulik PK, Varma TR, Vora JP Vinjamuri S (2002) The role of somatostatin receptor scintigraphy in the management of pituitary tumours. Nucl Med Commun 23, 117 120.
7. Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP Breeman WA (2003) Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs. J Nucl Med 44, 1315 1321.
8. Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, Erchegyi J, Rivier J, Macke HR Reubi JC (2006) Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci USA 103, 16436 16441.
9. Storch D, Behe M, Walter MA, Chen J, Powell P, Mikolajczak R Macke HR (2005) Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization? J Nucl Med 46, 1561 1569.
10. Hukovic N, Panetta R, Kumar U Patel YC (1996) Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 137, 4046 4049.
11. Roosterman D, Kreuzer OJ, Brune N, Cottrell GS, Bunnett NW, Meyerhof W Steinhoff M (2007) Agonist-induced endocytosis of rat somatostatin receptor 1. Endocrinology 148, 1050 1058.
12. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC Schonbrunn A (2005) Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol 68, 90 101.
13. Roosterman D, Kempkes C, Cottrell GS, Padilla BE, Bunnett NW, Turck CW Steinhoff M (2008) Endothelin-converting enzyme-1 degrades internalized SST-14. Endocrinology 149, 2200 2207.
14. Ferone D, van Hagen MP, Kwekkeboom DJ, van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E, Schonbrunn A, Colao A, Lamberts SW Hofland LJ (2000) Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro. J Clin Endocrinol Metab 85, 1719 1726.
15. Roth A, Kreienkamp HJ, Meyerhof W Richter D (1997) Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization. J Biol Chem 272, 23769 23774.
16. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V Schulz S (2004) Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279, 21374 21382.
17. Roosterman D, Cottrell GS, Padilla BE, Muller L, Eckman CB, Bunnett NW Steinhoff M (2007) Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling. Proc Natl Acad Sci USA 104, 11838 11843.
18. Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A et al. (2006) Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med 47, 502 511.
19. Presky DH Schonbrunn A (1986) Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells. J Cell Biol 102, 878 888.
20. Roosterman D, Roth A, Kreienkamp HJ, Richter D Meyerhof W (1997) Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells. J Neuroendocrinol 9, 741 751.
21. Lucius R Mentlein R (1991) Degradation of the neuropeptide somatostatin by cultivated neuronal and glial cells. J Biol Chem 266, 18907 18913.
22. Mentlein R Dahms P (1994) Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J Neurochem 62, 27 36.
23. Delbruck R, Desel C, von Figura K Hille-Rehfeld A (1994) Proteolytic processing of cathepsin D in prelysosomal organelles. Eur J Cell Biol 64, 7 14.
24. Roth A, Kreienkamp HJ, Nehring RB, Roosterman D, Meyerhof W Richter D (1997) Endocytosis of the rat somatostatin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs. DNA Cell Biol 16, 111 119.
25. Kreuzer OJ, Krisch B, Dery O, Bunnett NW Meyerhof W (2001) Agonist-mediated endocytosis of rat somatostatin receptor subtype 3 involves beta-arrestin and clathrin coated vesicles. J Neuroendocrinol 13, 279 287.
26. Padilla B, Cottrell GS, Roosterman D, Pikios S, Muller L, Steinhoff M Bunnett NW (2007) Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins. J Cell Biol 179, 981 997.
27. Mellman I (1996) Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12, 575 625.
28. Zitzer H, Honck HH, Bachner D, Richter D Kreienkamp HJ (1999) Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain. J Biol Chem 274, 32997 33001.
29. Wente W, Stroh T, Beaudet A, Richter D Kreienkamp HJ (2005) Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. J Biol Chem 280, 32419 32425.
30. Lamberts SW, Krenning EP Reubi JC (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12, 450 482.
31. Roosterman D, Cottrell G, Schmidlin F, Steinhoff M Bunnett NW (2004) Recycling and resensitization of the neurokinin 1 receptor: influence of agonist concentration and RAB GTPases. J Biol Chem 279, 30670 30679.
32. Bodansky M Bodansky A (1994) The practice of peptide synthesis, 2nd edn. Springer-Verlay, New York, NY.
33. Presky DH Schonbrunn A (1988) Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J Biol Chem 263, 714 721.